← Health Catalyst, Inc.
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue: | $73.1m | $112.6m | $154.9m | $188.8m | $241.9m | $276.2m | $295.9m | $306.6m | $311.1m | $292.2m | |
| Total cost of revenue, excluding depreciation and amortization | $43.6m |
$59.9m
+37.14%
|
$75.3m
+25.89%
|
$98.1m
+30.17%
|
$124.4m
+26.79%
|
$143.0m
+15.03%
|
$164.1m
+14.72%
|
$165.8m
+1.04%
|
$159.5m
-3.83%
|
— | |
| Research and development | $28.5m | $38.6m | $46.3m | $53.5m | $62.7m | $75.7m | $72.6m | $58.0m | $49.8m | $43.0m | |
| Sales and marketing | $25.9m | $44.1m | $47.3m | $55.4m | $75.0m | $87.5m | $67.3m | $54.4m | $52.5m | — | |
| General and administrative | $14.7m | $22.7m | $31.7m | $59.2m | $85.9m | $61.7m | $76.6m | $56.8m | $49.6m | $48.0m | |
| Total operating expenses | $75.0m | $112.8m | $134.5m | $186.9m | $261.2m | $273.2m | $258.7m | $210.6m | $312.5m | $326.9m | |
| Loss from operations | ($45.5m) |
($60.1m)
-31.96%
|
($54.9m)
+8.70%
|
($96.1m)
-75.20%
|
($143.7m)
-49.44%
|
($140.0m)
+2.54%
|
($126.9m)
+9.36%
|
($69.8m)
+44.99%
|
($160.9m)
-130.43%
|
— | |
| Loss before income taxes | ($47.0m) | ($62.1m) | ($60.0m) | ($116.2m) | ($160.1m) | ($141.7m) | ($117.8m) | ($69.2m) | ($177.3m) | — | |
| Income tax provision | $26k | ($135k) | $142k | ($1.2m) | ($6.9m) | ($4.3m) | $356k | $333k | $716k | — | |
| Net loss | ($47.0m) | ($62.0m) | ($60.1m) | ($115.0m) | ($153.2m) | ($137.4m) | ($118.1m) | ($69.5m) | ($178.0m) | — | |
| Net loss per share, basic (in USD per share) | — | — | ($13) | ($3) | ($3) | ($3) | ($2) | ($1) | ($3) | — | |
| Net loss per share, diluted (in USD per share) | — | — | ($13) | ($3) | ($3) | ($3) | ($2) | ($1) | ($3) | — | |
| Weighted-average shares outstanding used in calculating net loss per share, basic (in shares) | — | — | (3) | (3) | (3) | (3) | (2) | (1) | (3) | — | |
| Weighted-average shares outstanding used in calculating net loss per share, diluted (in shares) | — | — | (3) | (3) | (3) | (3) | (2) | (1) | (3) | — | |
| Depreciation and amortization | $5.9m | $7.4m | $9.2m | $18.7m | $37.5m | $48.3m | $42.2m | $41.4m | $50.5m | $48.6m | |
| Impairment of goodwill and intangible assets | — | — | — | — | — | — | $0 | $0 | $110.2m | — | |
| Interest and other (expense) income, net | — | — | — | — | — | ($1.7m) | $9.1m | $637k | ($16.4m) | — |